血液透析和持续不卧床腹膜透析患者恶性肿瘤发病率对比分析  

Analysis on morbidity of malignant tumor in the patients with hemodialysis and continuance ambulatory peritoneal dialysis

作　　者：安坤 

机构地区：[1]大连市金州区第一人民医院肾内科,辽宁大连116100

出　　处：《中国医药导报》2010年第31期37-38,共2页China Medical Herald

摘　　要：目的:对比分析血液透析患者和持续不卧床腹膜透析患者恶性肿瘤发病率及临床特点。方法:选择2008年1月～2010年1月在我医院行血液透析治疗的患者70例,持续不卧床腹膜透析患者60例,对比分析恶性肿瘤的发生情况及临床特点。结果:70例血液透析患者中6例发生恶性肿瘤,发病率为8.5%。60例持续不卧床腹膜透析患者2例发生恶性肿瘤,发病率为3.3%。两组比较,有显著性差异(P<0.01)。血液透析患者消化系统肿瘤发病率较高、持续不卧床腹膜透析患者肺癌发病率较血液透析患者高。结论:血液透析患者恶性肿瘤发病率明显高于腹膜透析患者。Objective： To evaluate the incidence of malignant tumors and its related factors,in patients including hemodialysis and continuance ambulatory peritoneal dialysis.Methods： We recruited 70 cases of patients with hemodialy-sis and 60 cases of patients with continuance ambulatory peritoneal dialysis in our hospital,then a cross sectional study to investigate the incidence and the clinical features of malignant tumors.Results： Among the 70 hemodialysis patients,6 case（8.5%） developed malignant tumors,and among 60 continuance ambulatory peritoneal dialysis patients,2 case（3.3%） developed malignant tumors.There was a significant difference in two groups（P〈0.01）.The incidence of digestive system tumors was quite high in hemodialysis patients,but lung caner was high in the patients with continuance ambulatory peri-toneal dialysis.Conclusion： The incidence of malignant tumors in hemodialysis patients is higher than that in continuance ambulatory peritoneal dialysis patients.

关 键 词：血液透析 持续不卧床腹膜透析 恶性肿瘤 

分 类 号：R459.5[医药卫生—治疗学]